Rennova Health (Rennova Health) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Rennova Health ROE % Adjusted to Book Value?

Rennova Health's ROE % for the quarter that ended in Sep. 2023 was 0.00%. Rennova Health's PB Ratio for the quarter that ended in Sep. 2023 was N/A. Rennova Health's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 was N/A.

Rennova Health ROE % Adjusted to Book Value Historical Data

The historical data trend for Rennova Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rennova Health ROE % Adjusted to Book Value Chart

Rennova Health Annual Data

Trend

Mar13

Mar14

Mar15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

Negative Equity

Rennova Health Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	Negative Equity	Negative Equity	Negative Equity	-

Competitive Comparison of Rennova Health's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Rennova Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rennova Health's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rennova Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Rennova Health's ROE % Adjusted to Book Value falls into.

Rennova Health ROE % Adjusted to Book Value Calculation

Rennova Health's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Rennova Health's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Rennova Health ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Rennova Health's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Rennova Health (Rennova Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rennova Health Inc (OTCPK:RNVA) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 S. Australian Avenue, Suite 800, West Palm Beach, FL, USA, 33401

Website

https://www.rennovahealth.com

Rennova Health Inc is a vertically integrated provider of healthcare-related products and services. The company operates through a single business segment namely the Hospital operations segment reflects the purchase of the hospital assets. Geographically, the activities are carried out throughout the region of the US.

Executives

Jonathan Immordino	officer: Chief Financial Officer	3340, POSEIDON WAY, INDIALANTIC FL 32903
Marlene Mclennan	officer: Chief Financial Officer	400 SOUTH AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401
Gary L Blum	director	3278 WILSHIRE BOULEVARD, SUITE 603, LOS ANGELES, CALIFORNIA CA 90010
John Beach	director	400 S. AUSTRALIAN AVENUE,, SUITE 800,, WEST PALM BEACH, FL 33401
Kamran Ajami	director	3920 NW 43RD ST., COCONUT CREEK FL 33073
Trevor Langley	director	1000 N. GREEN VALLEY PARKWAY, #440-420, HENDERSON NV 89074
Michael H Pollack	officer: Interim CFO	114 WEST 47TH STREET, 19TH FLOOR, NEW YORK NY 10036
Sharon Lynne Hollis	10 percent owner	400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Robert P Lee	director	400 S. AUSTRALIAN AVE., #800, WEST PALM BEACH FL 33134
Aella, Ltd.	10 percent owner	SUITE 104A, SAFFREY SQUARE, BANK LANE, PO BOX N-9306, NASSAU C5 000000
Epizon Ltd.	10 percent owner	SUITE 104A, SAFFREY SQUARE, BANK LANE, PO BOX N-9306, NASSAU C5 000000
Michael Louis Goldberg	director	2008 BAYVIEW DRIVE, FORT LAUDERDALE FL 33305
Benjamin Frank	director	400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Jason Adams	officer: Chief Financial Officer	4700 SANTA DEL RAE AVENUE, FT MYERS FL 33901
George Lundberg	officer: Editor in Chief and CMO	44 MONTGOMERY STREET, SUITE 800, SAN FRANCISCO CA 94104